Lipella Pharmaceuticals Inc. (LIPO): Revenue
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$536.4K
Year ended 2024-12-31
$389.8K
Trailing 12 months to 2025-09-30
+27.4%
3-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $536.4K | +19.3% | 2025-03-28, From 2024-01-01 |
| 2023-12-31 | $449.6K | +144.2% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $184.2K | -29.0% | 2024-02-27, From 2022-01-01 |
| 2021-12-31 | $259.3K | n/a | 2023-03-31, From 2021-01-01 |